Shanghai AI Laboratory Launches Innovative ViraHInter Model to Enhance Efficiency in Antiviral Drug Development
The Shanghai Artificial Intelligence Laboratory, in collaboration with multiple institutions, has introduced the ViraHInter AI model, which can predict interactions between viruses and human proteins without wet experiments. By combining sequence and structure bimodal analysis, it has ushered in a new stage in antiviral drug development.